Cargando…

Cardiovascular morbidity and mortality in patients with type 2 diabetes using novel antidiabetic medicines as add-on therapy: an observational real-world study

OBJECTIVE: To evaluate the effect of sodium-glucose co-transporter 2 inhibitors (SGLT2i) and glucagon-like peptide-1 receptor agonists (GLP-1RA), compared with dipeptidyl peptidase-4 inhibitors (DPP-4i) as add-on therapy on cardiovascular (CV) morbidity and mortality in patients with type 2 diabetes...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zerovnik, Spela, Kos, Mitja, Locatelli, Igor
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BMJ Publishing Group 2021
Materias:	Diabetes and Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8438902/ https://www.ncbi.nlm.nih.gov/pubmed/34518273 http://dx.doi.org/10.1136/bmjopen-2021-051549

Ejemplares similares

Risk of lower extremity amputations in patients with type 2 diabetes using sodium-glucose co-transporter 2 inhibitors
por: Zerovnik, Spela, et al.
Publicado: (2021)

Cardiovascular mortality and oral antidiabetic drugs: protocol for a systematic review and network meta-analysis
por: Goyat, Rashmi, et al.
Publicado: (2017)

Uptake of new antidiabetic medicines in 11 European countries
por: Mardetko, Nika, et al.
Publicado: (2021)

Comparative cardiovascular morbidity and mortality in patients taking different insulin regimens for type 2 diabetes: a systematic review
por: Price, Hilary I, et al.
Publicado: (2015)

Prediction of morbidity and mortality in patients with type 2 diabetes
por: Wells, Brian J., et al.
Publicado: (2013)

Impacts of type 2 diabetes mellitus and hypertension on the incidence of cardiovascular diseases and stroke in China real-world setting: a retrospective cohort study
por: Liu, Yan, et al.
Publicado: (2021)

Changing use of antidiabetic drugs in the UK: trends in prescribing 2000–2017
por: Wilkinson, Samantha, et al.
Publicado: (2018)

All-cause mortality following low-dose aspirin treatment for patients with high cardiovascular risk in remote Australian Aboriginal communities: an observational study
por: Zhao, Yuejen, et al.
Publicado: (2020)

Potential antidiabetic effect of ethanolic and aqueous-ethanolic extracts of Ricinus communis leaves on streptozotocin-induced diabetes in rats
por: Gad-Elkareem, Mohamed A.M., et al.
Publicado: (2019)

Prevalence and Incidence of Frailty Among Community-dwelling Older Adults in Slovenia
por: Jazbar, Janja, et al.
Publicado: (2021)

Glycaemic control efficacy of oral antidiabetic drugs in treating type 2 diabetes: a protocol for network meta-analysis
por: Jia, Yongliang, et al.
Publicado: (2015)

Use of multiple antidiabetic medications in patients with diabetes and its association with hypoglycaemic events: a case-crossover study in Jordan
por: Naser, Abdallah Y, et al.
Publicado: (2018)

Antidiabetic and antiosteoporotic pharmacotherapies for prevention and treatment of type 2 diabetes-induced bone disease: protocol for two network meta-analyses
por: Deng, Jiawen, et al.
Publicado: (2020)

Real-world evidence studies into treatment adherence, thresholds for intervention and disparities in treatment in people with type 2 diabetes in the UK
por: McGovern, Andrew, et al.
Publicado: (2016)

The Effect of Glycemic Control on Morbidity and Mortality in Critically Ill COVID-19 Patients
por: Sultan, Kinza, et al.
Publicado: (2023)

Cross-sectional comparison of point-of-care with laboratory HbA(1c) in detecting diabetes in real-world remote Aboriginal settings
por: Marley, Julia V, et al.
Publicado: (2015)

The Cardiovascular Benefits Associated with the Use of Sodium-Glucose Cotransporter 2 Inhibitors – Real-World Data
por: Gallwitz, Baptist
Publicado: (2018)

Randomised cross-over trial of vildagliptin and pioglitazone as add-on therapy in patients with type 2 diabetes: predicting Which One is Right Here (WORTH) study protocol
por: Yeu, Rui Qian, et al.
Publicado: (2020)

Cohort profile: Outcomes & Multi-morbidity In Type 2 diabetes (OMIT) – a national registry-based observational cohort with focus on care and treatment of key high-risk groups in Norway
por: Forster, Rachel B, et al.
Publicado: (2022)

Glycaemic control and antidiabetic treatment trends in primary care centres in patients with type 2 diabetes mellitus during 2007–2013 in Catalonia: a population-based study
por: Mata-Cases, Manel, et al.
Publicado: (2016)

Oral antidiabetic medication adherence and glycaemic control among patients with type 2 diabetes mellitus: a cross-sectional retrospective study in a tertiary hospital in Saudi Arabia
por: Balkhi, Bander, et al.
Publicado: (2019)

Real-world Evaluation of glycemic control and hypoglycemic Events among type 2 Diabetes mellitus study (REEDS): a multicentre, cross-sectional study in Thailand
por: Satirapoj, Bancha, et al.
Publicado: (2020)

Contribution of temporal data to predictive performance in 30-day readmission of morbidly obese patients
por: Povalej Brzan, Petra, et al.
Publicado: (2017)

Real-World Observational Study of Glimepiride and Metformin Fixed-Dose Combination Along With Insulin in the Management of Type 2 Diabetes Mellitus: Indian Experience
por: Prasanna Kumar, KM, et al.
Publicado: (2021)

Relationship between percentage of mean arterial pressure at the ankle and mortality in participants with normal ankle-brachial index: an observational study
por: Li, Yu-Hsuan, et al.
Publicado: (2016)

Real-world outcomes of US employees with type 2 diabetes mellitus treated with insulin glargine or neutral protamine Hagedorn insulin: a comparative retrospective database study
por: Wang, Li, et al.
Publicado: (2013)

Comparative efficacy of once-weekly semaglutide versus SGLT-2 inhibitors in patients inadequately controlled with one to two oral antidiabetic drugs: a systematic literature review and network meta-analysis
por: Kanters, Steve, et al.
Publicado: (2019)

Cardiovascular Outcome Studies With Novel Antidiabetes Agents: Scientific and Operational Considerations
por: Hirshberg, Boaz, et al.
Publicado: (2013)

Multiple risk factor control, mortality and cardiovascular events in type 2 diabetes and chronic kidney disease: a population-based cohort study
por: Hamada, Shota, et al.
Publicado: (2018)

Aspirin treatment and risk of first incident cardiovascular diseases in patients with type 2 diabetes: an observational study from the Swedish National Diabetes Register
por: Ekström, Nils, et al.
Publicado: (2013)

Glimepiride and Metformin Combinations in Diabetes Comorbidities and Complications: Real-World Evidence
por: Sahay, Rakesh Kumar, et al.
Publicado: (2020)

Patterns of weight change after the diagnosis of type 2 diabetes in Scotland and their relationship with glycaemic control, mortality and cardiovascular outcomes: a retrospective cohort study
por: Aucott, Lorna S, et al.
Publicado: (2016)

Is There Evidence That Oral Hypoglycemic Agents Reduce Cardiovascular Morbidity or Mortality? No
por: Kassem, Sameer A., et al.
Publicado: (2009)

Higher Inpatient Morbidity and Mortality in Biliary Pancreatitis Compared to Hypertriglyceridemia-Induced Pancreatitis: A Nationwide Retrospective Study
por: Shaka, Hafeez, et al.
Publicado: (2020)

Effectiveness and cost of integrating a pragmatic pathway for prescribing liraglutide 3.0 mg in obesity services (STRIVE study): study protocol of an open-label, real-world, randomised, controlled trial
por: Papamargaritis, Dimitris, et al.
Publicado: (2020)

Association between refill adherence to lipid-lowering medications and the risk of cardiovascular disease and mortality in Swedish patients with type 2 diabetes mellitus: a nationwide cohort study
por: Karlsson, Sofia Axia, et al.
Publicado: (2018)

Real-World Observational Study on Vildagliptin With Insulin (VIL-INS) or Vildagliptin and Metformin With Insulin (VIL-MET-INS) Therapy in Indian Patients With Type 2 Diabetes Mellitus
por: Panneerselvam, P, et al.
Publicado: (2023)

New Diabetes Questionnaire to add patients’ perspectives to diabetes care for adults with type 1 and type 2 diabetes: nationwide cross-sectional study of construct validity assessing associations with generic health-related quality of life and clinical variables
por: Svedbo Engström, Maria, et al.
Publicado: (2020)

Diabetes status and other factors as correlates of risk for thrombotic and thromboembolic events during SARS-CoV-2 infection: A nationwide retrospective case–control study using Cerner Real-World Data™
por: Tallon, Erin M, et al.
Publicado: (2023)

Real-world evidence on the use of a fixed-ratio combination of insulin glargine and lixisenatide (iGlarLixi) in people with suboptimally controlled type 2 diabetes in Romania: a prospective cohort study (STAR.Ro)
por: Bala, Cornelia, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_cb87db6csbmtjv9o2201fgnbai